Navigation Links
Vicept Therapeutics Announces Positive Clinical Study Results of V-101 for the Treatment of the Erythema of Rosacea
Date:8/5/2010

MALVERN, Pa., Aug. 5 /PRNewswire/ -- Vicept Therapeutics, Inc., a privately held specialty biopharmaceutical company, announced positive results today from a pharmacodynamic and pharmacokinetic clinical trial of the Company's lead product V-101, a topical cream under investigation for the treatment of erythema in patients with rosacea.

The double-blinded, placebo-controlled, crossover clinical trial of 22 patients with rosacea was designed to evaluate the bioavailability of V-101 and provide preliminary evidence of efficacy as measured by improvement in moderate to severe erythema, the bright redness of the skin associated with rosacea.  V-101 had a side effect profile similar to placebo and V-101's active ingredient was not detectable in study participants' plasma, a strong indication of the product's overall tolerability and safety profile.  Additionally, the study results were positive for all endpoints, demonstrating a clinically and statistically significant improvement in treating the erythema associated with rosacea.

"This important study demonstrated that V-101 has a good safety profile and provides statistically significant evidence of effectiveness in treating the erythema of rosacea," said Dr. Neal Walker, president and chief executive officer of Vicept. "We look forward to advancing our clinical program into Phase II and continuing our efforts to develop this product for the 16 million people in the United States who live with this common, chronic skin condition every day."

"Rosacea is devastating to people who live with it and the primary complaint is erythema, the red sunburn appearance that accompanies the disease," said James Leyden, M.D., Professor E
'/>"/>

SOURCE Vicept Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. CMP Therapeutics Appoints Dr Neill Moray Mackenzie as CEO
2. United Therapeutics Corporation to Announce Second Quarter 2010 Financial Results Before Market Open on Wednesday, July 28, 2010
3. Aegera Therapeutics Reports Survival Data from the Phase 1 Portion of its Phase 1-2 Study of AEG35156 in Combination with Sorafenib in Patients with Advanced Hepatocellular Carcinoma
4. Talecris Biotherapeutics to Report Second Quarter 2010 Financial Results
5. Talecris Biotherapeutics Announces Premerger HSR Filing
6. Lafmin Morgan Joins Talecris Biotherapeutics as Vice President, U.S. Product Management
7. Northwest Biotherapeutics Raises Funding and Proceeds With Balance Sheet Restructuring
8. Silence Therapeutics Expands RNAi Structural Modification IP Portfolio With Issuance of New U.S. Patent
9. United Therapeutics and Lees Pharmaceutical Sign Remodulin Distribution Agreement for China
10. Precision Therapeutics Growing Rapidly as it Augments Research and Development Efforts
11. Sirnaomics Receives Two SBIR Grants from NIH for Developing siRNA Therapeutics to Treat Glioblastoma and Influenza Infection
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... California (PRWEB) May 06, 2015 ... Dots, a type of nanomaterial with diameter ranging ... product in the global nanophotonics materials market. The ... quantum dots due to quantum confinement effect render ... a wide range of scientific, technological, and commercial ...
(Date:5/6/2015)... BALTIMORE , May 6, 2015   University ... LLC announced today the signing of an exclusive ... of Maryland, Baltimore (UMB) to develop diagnostics to detect ... and Crohn,s disease (CD). Drs. Florian Fricke ... while both were with the University of Maryland School ...
(Date:5/6/2015)... 2015  Oxis Biotech, Inc. (OXIS), a wholly owned ... today that Cassian Yee , M.D., Professor, Department ... the University of Texas MD Anderson Cancer Center joined ... Department of Immunology, Division of Cancer Medicine, and Director, ... at the University of Texas MD Anderson Cancer Center.  ...
(Date:5/6/2015)... Whitefox ( http://www.whitefox.com ... has signed an agreement with  California ... the delivery of an industrial scale membrane system. The ... water, energy and emissions in the production ... project is fully aligned with ...
Breaking Biology Technology:Expanding Applications & Full-Scale Commercialization to Drive the Global Quantum Dots Market, According to a New Report by Global Industry Analysts, Inc. 2Expanding Applications & Full-Scale Commercialization to Drive the Global Quantum Dots Market, According to a New Report by Global Industry Analysts, Inc. 3Biomecite Diagnostics Signs Option Agreement with UM Baltimore to Develop Tools to Detect Inflammatory Bowel Diseases 2Biomecite Diagnostics Signs Option Agreement with UM Baltimore to Develop Tools to Detect Inflammatory Bowel Diseases 3Oxis Biotech Appoints Cassian Yee, M.D. To Its Scientific Advisory Board 2Oxis Biotech Appoints Cassian Yee, M.D. To Its Scientific Advisory Board 3Whitefox Signs Agreement With Pacific Ethanol Inc. 2
... levels of vitamin B12 using your breath, allowing for a ... the potentially fatal symptoms of B12 deficiency. In ... Journal of Breath Research , researchers have developed a ... B12. Vitamin B12 deficiency is a growing public ...
... CLEVELAND, June 22, 2011 Clinical Research Management, ... in basic and applied research, clinical trials, and ... a new, 5-year, $97MM research support contract titled ... (SMMRS) to be performed at the Walter Reed ...
... Wash., June 22, 2011 CMC Biologics today announced ... its stainless steel biopharmaceutical production facility at its Bothell ... an exciting new logo and a compelling tagline. These ... the Company. (Logo:   http://photos.prnewswire.com/prnh/20110502/SF93356LOGO ) ...
Cached Biology Technology:A breath of fresh air for detecting vitamin B12 deficiency 2ClinicalRM (formerly CRM) Awarded $97MM U.S. Army Contract to Support Military Clinical Research for the Warfighter 2CMC Biologics Expands Its Production Facility and Rebrands Its Corporate Identity 2
(Date:4/6/2015)... Apr. 6, 2015 NXT-ID, Inc. (NASDAQ: ... authentication company focused on the growing mobile commerce ... patent 62/143028 for MINIATURE, MULTI-PURPOSE ANTENNA ... NXT-ID introduces a new revolutionary method ... surrounds the use of miniature antenna modules for ...
(Date:4/2/2015)... , April 2, 2015 Fingerprint ... fingerprint sensor FPC1025 from the distributor World Peace Industrial ... during Q2 2015 although the major part of the ... will be used by smartphone manufacturers in ... is included in the communicated revenue guidance of + ...
(Date:3/31/2015)...   Guidepoint , a leading global research services ... Management TRACKER, part of the Guidepoint TRACKER ... medical device and therapeutics markets. The Post-Surgical Pain Management ... market share, and adoption rates across three major modalities ... The Post-Surgical Pain Management TRACKER will provide ...
Breaking Biology News(10 mins):NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 2NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 3NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 4Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 110 Million 2Guidepoint Launches Post-Surgical Pain Management TRACKER 2Guidepoint Launches Post-Surgical Pain Management TRACKER 3
... in the Yukon River Basin provide unique insights on ... for these local communities. The USGS coordinated ... of St. Mary,s and Pitka,s Point, Alaska, to document ... from safety, such as unpredictable weather patterns and dangerous ...
... system developed by researchers at the San Diego Supercomputer ... has been used in the first global camera trap ... by emphasizing the importance of protected areas to ensure ... animal populations. The study, led by Jorge Ahumada, ...
... Durham, NC, is honored by the American Society for ... Award for his work studying the molecular and genetic ... responses against intracellular pathogens. Sponsored by Merck, U.S. Human ... for research excellence in microbiology and infectious diseases. Dr. ...
Cached Biology News:Observations of climate change from indigenous Alaskans 2Observations of climate change from indigenous Alaskans 3SDSC-developed software used in first global camera trap mammal study 2SDSC-developed software used in first global camera trap mammal study 3The American Society for Microbiology honors Jörn Coers 2
... carry-over contamination, which prevents false positive ... from previous PCR amplifications without degrading ... amplification ,Optimized for use with GeneAmp ... systems , The GeneAmp PCR Carry-over ...
... Heraeus HERAsafe KS convince with an optimum product, ... frameless slanted window does not obscure the view ... design makes it easy to work in a ... height of more than 250 mm ensures ease ...
... Fluoroskan Ascent FL is ... and luminometric measurement technologies ... list of advanced features ... Luminoskan Ascent. Fluoroskan Ascent ...
... orbital shaker stands both present ... ergonomic height, and help protect ... welded tubular steel, these heavy-duty ... the weight and minimize the ...
Biology Products: